0001829255-20-000001.txt : 20201022 0001829255-20-000001.hdr.sgml : 20201022 20201022132248 ACCESSION NUMBER: 0001829255-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201022 DATE AS OF CHANGE: 20201022 EFFECTIVENESS DATE: 20201022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Halia Therapeutics, Inc. CENTRAL INDEX KEY: 0001829255 IRS NUMBER: 822679083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-378597 FILM NUMBER: 201253544 BUSINESS ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: 801-753-5707 MAIL ADDRESS: STREET 1: 222 S. MAIN STREET, SUITE 500 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 D 1 primary_doc.xml X0708 D LIVE 0001829255 Halia Therapeutics, Inc. 222 S. MAIN STREET, SUITE 500 SALT LAKE CITY UT UTAH 84101 801-753-5707 DELAWARE None None Corporation true 2017 Jared Bearss 222 S. Main Street, Suite 500 Salt Lake City UT UTAH 84101 Executive Officer Director Promoter David Bearss 222 S. Main Street, Suite 500 Salt Lake City UT UTAH 84101 Executive Officer Director Promoter John S.K. Kauwe 222 S. Main Street, Suite 500 Salt Lake City UT UTAH 84101 Director Promoter Jim Savas 222 S. Main Street, Suite 500 Salt Lake City UT UTAH 84101 Director Mike McCullar 222 S. Main Street, Suite 500 Salt Lake City UT UTAH 84101 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-10-09 false true true false 0 15000000 6344990 8655010 false 9 0 0 0 false Halia Therapeutics, Inc. /s/ Jared Bearss Jared Bearss Chief Operating Officer 2020-10-22